News Home Page
Access the 15 most recent news items below. For older items, please click the 'view archives' link in the lower right.
Qiagen Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs
QIAGEN has recently launched new Investigator STR assay kits for analysis of DNA evidence in forensic laboratories in the United States. The new genetic fingerprint kits provide an integrated solution to simultaneously analyze multiple key genomic markers (short tandem repeats or STRs) for DNA matching. They incorporate the Investigator Quality Sensor to evaluate the quality of DNA in each sample, a novel QIAGEN technology that enables labs to decide quickly which evidence ...
Posted on: July 07, 2015
Pathologists to Unlock the Secrets of Diagnosing Elusive Castleman's Disease
Two world-renowned diagnosticians on rare diseases will address the challenges of diagnosing Castleman's disease-a disease that is extremely difficult to diagnose because its symptoms can mimic other diseases, such as lymphoma, mononucleosis, and lupus-during a free, special session on July 29, 7 to 9 a.m., at the 2015 ASCP Pathology Update, Encore at Wynn Las Vegas, 3131 Las Vegas Blvd. South, Nev. 89109.In the session titled, "Castleman's Disease 2015: Pathogenesis, Classification, Diagnosis, ...
Posted on: July 06, 2015
Protagen AG Achieves Significant Milestone with ISO 13485 Certification
Protagen AG, a company concerned with the development of advanced diagnostic tools to address some of the most severe autoimmune diseases, has received the ISO 13485 certification, and now officially complies with the internationally recognized quality standard for medical devices.The ISO 13485 certification covers the development, production and distribution of in-vitro diagnostics (IVD) for autoimmune diseases. The certificate demonstrates that Protagen has successfully implemented a quality management ...
Posted on: July 05, 2015
Beazley Offers Management Liability Coverage for Healthcare Providers
Beazley Group, a specialist insurer of risks affecting healthcare providers, has launched Beazley Remedy, the first admitted management liability coverage that includes a regulatory liability coverage option.Healthcare providers operate in an increasingly hazardous regulatory environment, with highly complex coding requirements. Providers across the country are readying their systems and processes for the ICD-10 revision mandate scheduled for Oct. 1 of this year. Beazley Remedy offers robust ...
Posted on: July 03, 2015
New Protein Analysis Kit Provides Sensitive, Reproducible and Fast Results
A new tool for protein digestion is designed to substantially reduce preparation times and associated errors, facilitating fast and reliable analytical results for biopharmaceutical and protein research applications.Current protein digestion techniques are comprised of complex procedures that require the determination of protein concentration, followed by sample reduction and alkylation steps prior to digestion with trypsin. This multifaceted preparation protocol can take up to 24 hours and is prone to ...
Posted on: July 02, 2015
Novacyt Launches Molecular HPV Service to Its Novaprep Customers
Novacyt, an international specialist in cancer and infectious disease diagnostics, has launched a molecular HPV service for all its customers who currently use its next generation NOVAprep liquid-based cytology platform for cervical cancer screening.Novacyt will offer the new service using Abbott's RealTime High Risk HPV PCR assay and customers will be able to use the same NOVAprep consumable vial and medium for both Novacyt's cytology platform and for Abbott's assay.Novacyt has validated the ...
Posted on: July 01, 2015
Researchers Identify New Class of Antifungal Agents
Researchers have identified a new class of antifungals to treat the more than 300 million people worldwide who develop serious fungal infections. The research is described in the current issue of mBio, the online open-access journal of the American Society for Microbiology."Fungal infections are a significant cause of morbidity and mortality worldwide and current antifungal drugs have drawbacks. These new drugs may pave the way for the development of a new class of antifungals," said principal ...
Posted on: June 30, 2015
Cyrex Labs Launches Array 3 Gluten/Wheat Reactivity And Autoimmunity Test Panel
Cyrex Laboratories, a clinical laboratory specializing in functional immunology and autoimmunity, launched its Array 3 Wheat/Gluten Proteome Reactivity and Autoimmunity test panel to provide healthcare professionals with accurate results in identifying their patient's gluten reactivity and related autoimmunity.Cyrex Array 3 is the only wheat/gluten panel that assesses three antigen triggers of disorders (gluten proteins, opioid peptides and tissue binding isolates), "Based on articles published in ...
Posted on: June 29, 2015
Luminex Corporation Begins Clinical Trials for ARIES GBS Assay
Luminex Corporation has commenced clinical and analytical studies to evaluate the company's ARIES Group B Streptococcus (GBS) Assay. The clinical trials are being conducted at several clinical laboratories in the U.S., and Luminex still expects its FDA submission for the ARIES platform and ARIES HSV 1&2 Assay to occur in the summer of 2015.One in four pregnant women are colonized with Group B Streptococcus (GBS), also known as Streptococcus agalactiae. If not treated, GBS can be transmitted to a ...
Posted on: June 28, 2015
R2R Biofluidics Declares War on Hospital-Acquired Infections
Excessive use of antibiotics in human medicine as well as in livestock breeding has led to a dramatic increase of drug resistant bacteria in hospitals. Therefore, new and cost-effective tests for the early detection of antibiotic-resistant bacteria are urgently needed. A large number of these tests must be carried out when developing new drugs to determine the effects of new substances in an early stage of development. Therefore, the Austrian research company Joanneum Research is coordinating ...
Posted on: June 26, 2015
ACA Subsidies Upheld by Supreme Court, but Health Needs Still Unmet: Doctors Group
Although the Supreme Court has upheld the premium subsidies under the Affordable Care Act, the law remains incapable of remedying the U.S. health crisis, according to one physician group. Physicians for a National Health Program, an organization of 19,000 doctors who support single-payer national health insurance, released the following statement:Today's decision by the Supreme Court in King v. Burwell to uphold the Affordable Care Act's premium subsidies in about three dozen states will spare more than 6 ...
Posted on: June 25, 2015
Ventana Gets FDA Approval for First Automated IHC Companion Diagnostic To Identify Lung Cancer Patients Eligible For XALKORI
Ventana Medical Systems' VENTANA ALK (D5F3) CDx Assay has been approved by the FDA as a companion diagnostic to aid in the identification of patients for Pfizer's FDA approved targeted therapy, XALKORI (crizotinib). The VENTANA ALK Assay was approved as a CE-IVD in Europe in 2012 and was approved by the Chinese Food and Drug Administration (CFDA) in 2013. With this US FDA Class III approval, ALK IHC testing is now widely accessible on VENTANA BenchMark1 immunohistochemistry (IHC) instruments ...
Posted on: June 25, 2015
Clinical value of Roche's CINtec PLUS Cytology Test Confirmed For Women With Abnormal Cervical Cytology Screening Results
Ventana Medical Systems, a member of the Roche Group, has published further results from the Primary ASC-US LSIL Marker Study (PALMS) in this month's issue of Cancer Cytopathology. The PALMS study, which enrolled more than 27,000 women from five European countries, was designed to evaluate the diagnostic performance of the CINtec PLUS Cytology2 test in detecting pre-cancerous cervical disease compared to HPV testing and more traditional screening methods like Pap cytology.In this ...
Posted on: June 23, 2015
Maine Standards Releases VALIDATE HbA1c Calibration Verification /Linearity Test Kit
Maine Standards Company has announced the release of its VALIDATE HbA1c calibration verification /linearity test kit which evaluates the percentage of Glycohemoglobin A1c in a human-whole-blood base matrix. Each VALIDATE HbA1c kit is prepared using the CLSI recommended "equal delta" method for linearity testing and is liquid, ready-to-use. Simply add the product from the dropper bottle directly into a sample cup and run as a patient sample in duplicate or triplicate.Release of this product will ...
Posted on: June 22, 2015
ZEISS and UC Berkeley Launch Partnership to Support Brain Microscopy Innovation Center
ZEISS is participating in a new public-private partnership with UC Berkeley as part of the Brain Microscopy Innovation Center (BrainMIC), a component of the Berkeley BRAIN Initiative. The Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative was launched by President Obama in 2013 and is focused on revolutionizing understanding of the human brain, with the goal of helping researchers uncover the mysteries of such brain disorders as Alzheimer's and Parkinson's diseases, ...
Posted on: June 22, 2015